ValiRx plc - Valiseek clinical development update
VAL
Thu, 03 Nov 2016, 09:00am GMT
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
Dr Suzy Dilly and Dr George Morris provide an update after their trip to Tbilisi on the clinical development of ValiRx's novel cancer treatment drug, VAL401. The clinic reported that as the first patient has proceeded sufficiently through the dosing phase of the protocol, the second patient is now approved to also commence dosing and the screening procedure for further enrolment continues to be underway.